SMAD2 and ovarian carcinoma: In experiments conducted on animals, suppressing miR-182A-3p reduced the formation of tumors, whereas overexpressing TGF1B led to an increase in the growth of tumors via ovarian carcinoma changing Smad2/3 phosphorylation.